Recurrent Colon Carcinoma Active Not Recruiting Phase 2 Trials for Camptothecin (DB04690)

Also known as: Carcinoma colon recurrent / Colon carcinoma recurrent / Colon cancer recurrent

DBCOND0047445 (Recurrent Colon Carcinoma)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT03365882S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by SurgeryTreatment